KoreTalkX #13 with Brian MacDonald


Rafael Gonçalves

Marketing and Communications


Rafael Gonçalves

Marketing and Communications

Brian MacDonald

Managing Director

ArcView Capital

Brian MacDonald

Managing Director

Rafael Gonçalves  00:46

Hello, everybody, good part of day. Good morning, good afternoon or good evening depending on where you’re listening watching us from or depending on which time you are listening to it on your podcast player. Very happy to be here. Rafael Goncalves, the communications coordinator for KoreConX. This is KoreTalkX number 13. Today we’re going to talk a little bit about the cannabis business which is controversial by itself. It’s growing a lot as well as a market. And I’m here with Brian McDonald from Arcview Capital, Brian, I’m very happy to have you here. Welcome. The stage is yours.


Brian MacDonald  01:24

Awesome. Awesome. Raphael. Thanks so much excited to be here. Thanks for having me today. We’re excited.


Rafael Gonçalves  01:31

That’s very good. That’s nice. So tell us a little bit more about you, Brian, about your background about what ArcView does. About what how, what do you guys do how you guys work? A little brief introduction of you and your company, please.


Brian MacDonald  01:45

Yeah, absolutely, absolutely. So my background is what some would consider very traditional with traditional financial services. So for the last 15 years, I’ve worked at very large asset management firms raising capital and a different fund structure. So whether it be a hedge fund, an ETF, a mutual fund, etc. And so I did that very successfully in the United States calling on a subset of advisors. And those advisors were typically registered investment advisors, or family offices, or independent broker dealer. So always, always focused on the financial advisor community. And so through that experience, I saw an opportunity with a mutual connection at my prior firm to enter into the cannabis industry. And the reason that I say that there’s an opportunity is that there’s something that’s somewhat missing in the cannabis industry. And that is the financial advisor being a part of the equation. And so that’s the opportunity yet, it’s also the challenge. And that’s really why I was so excited to join ArcView capital. So to take a step back ArcView capital is a registered broker dealer. We are an affiliate of the ArcView Group and the ArcView Group has been involved and an advocate for the cannabis industry for the past 12 years. So we’re really well known and positioned very well in the cannabis industry. And what we’re trying to do at ArcView Capital is not only leverage that expertise, that brand, that reputation in the cannabis industry, but get it to transcend into traditional financial services. So we’re very excited about everything that’s going on. And we know that it’s not the easiest of markets and the asset class and the area that we’re focused on. But because it is a tough road, that’s also what makes it so rewarding.


Rafael Gonçalves  03:31

Yeah, that’s nice. And just before we went live, you were telling me about something that just happened in the USA, right about Joe Biden, you can explain it better than I that I can.


Brian MacDonald  03:44

That’s right. And so I don’t want to miss misquote anything, or speak out of line here. But today’s October 6, and Joe Biden just announced that at a federal level, he’s going to be pardoning anybody that’s been arrested for any simple arrests for the possession of cannabis. So that’s going to have major impacts on markets and the like. So we’ll see how everything evolves from here. But one of the things that one of the things that very interesting about the asset class, just in general, is that everybody’s always talking about federal legalization. And when does federal legalization happen? That’s certainly an important part. But almost a bigger part is just when does normalization happen? When does society accept this not only accepted for the medicinal uses, but also just for adult use consumption, just like anything else, whether it be alcohol, tobacco, etc. So as that normalization continues to take place, we think that it’ll just create more and more opportunities for companies to flourish and to define different niches and different clients so that they can service throughout not only this industry, but but others as well because it does touch so many different industries that people don’t really realize today.


Rafael Gonçalves  05:00

Yes, exactly. That’s that’s that’s rather important to mention because the normalization, right, because society and a culture and not long ago, at least here in Brazil not long ago, people still thought it was strange for women to drink beer. I mean, what’s wrong with that? Right. But there’s not normalization comes with time, of course. And the federal legalization, I believe, would be the first step. And of course, we’re, we’re talking about it in October 6 2022. So things may change in the future or not. I mean, but this is definitely a huge step right here.


Brian MacDonald  05:44

Absolutely, absolutely. And the the analogy that I always like to give is that when I tell people that I’m in the cannabis industry and involved in the cannabis industry, just generally speaking, people always have some sort of idea in their mind and preconceived kind of stereotype. And that stereotype is all based on their own personal experience, and what their experience around cannabis has been. So whether that’s, you know, with a few friends behind a garage, a bad experience and good experience, it doesn’t matter, they always related to that experience. And what I always like to say is, well, it has such a broader and wider impact and can have a broader impact. And the analogy that I like to give is, you know, there’s a 65 year old woman, right, and this 65 year old woman who has never consumed cannabis in her life, do you think that she’s gonna go into a store and buy it pre roll joint? The answer is probably not. Right? But would she feel comfortable if she’s in her local drugstore, walking down the aisle, and she has trouble sleeping at night, and picking up something in a pill form that looks like everything else on the shelf, as part of the cannabis plant inside of it, that maybe is coupled with something like melatonin or fill in the blank that is just gonna help her sleep at night, she will probably buy that and consume that. That’s a whole different demographic than, you know, the people that are looking for pre rolled cannabis. Right. So it’s just another way to think about it. And just one example as to how wide and far this industry can, can go.


Rafael Gonçalves  07:15

Yes, exactly. And health, the health industry can benefit a lot, right? Because it’s a natural compounds. So that I mean, I mean, I see it, I always say that inside KoreConX. When we’re talking about cannabis. I see cannabis as a technology as research and technology, the same way we can research any kind of bland, or any kind of tree or fruit or any natural extract. I mean, it’s there, right? It’s it’s there. And it’s research, its technology, its research and technology. That’s basically how I think about it.


Brian MacDonald  07:53

That I mean, yeah, that’s exactly right. And if you look at history, and if you look at what has taken place over the past few decades, any research that was done around the plant, not all but a lot of the research was trying to show what was wrong with the plant, why it was bad for you. And now, just over the past few years, as the attitude has changed, as society has approached it and viewed it differently. Now, the studies aren’t around why it is bad for you, but how can some of the molecules within the plant actually benefit you? And how can we do things that are actually productive, and helping society? So the attitude is definitely changing. And it’s just this. We are just scratching the surface? That’s absolutely,


Rafael Gonçalves  08:33

yes. scratching the surface. Yeah, but you got to start somewhere, right? You gotta climb the ladder, you you always have the first step. So that’s right, maybe maybe history will tell us if this first step that Joe Biden just gave today, maybe? Who knows? Who knows. But so let’s, let’s move on from from the medical side, because we are not specialists on that. So. So you talked about normalization. And what do you believe that is the benefit for companies to work with a broker dealer that is open to talk about cannabis? Yeah, absolutely.


Brian MacDonald  09:13

Absolutely. And this, this is something that we’re super excited about, because as the farm bill passed, and when the farm bill passed, so that was that was a very big deal in the United States. And that made hemp federally legal, and to work with a broker dealer that’s focused on the cannabis industry. And we’re not just focused on the cannabis industry, right? We’re focused on the cannabis industry and other emerging industries, whether it be psychedelics, cryptocurrencies, etc. But because of our relationship, and our affiliation with the ArcView Group, we have tremendous insights into the cannabis industry. We can obviously rely on our partners that we have internally for different data points for research for commentary anecdotal information, consumer trends, etc. And by having those insights in those partnerships, that really gives us a competitive advantage. And so, for an individual company looking to work with a broker dealer, obviously, we feel like if it’s something that’s in our industry and in our focus and specialty, we just have a unique advantage that others just simply do not. And being affiliated with the ArcView group who’s been around for 12 years, they’ve been able to see firsthand the evolution of the industry, and how things have changed so dramatically, because I myself have only been involved in the cannabis industry for the past two years. And just in the past few years, I’ve seen how so much has evolved, right? Everything from insurance to banking, to fill in the blank it there are just so many different aspects of the industry, that if you don’t know how to navigate them, it could be very, very challenging for somebody.


Rafael Gonçalves  10:56

Yeah, I also have a have some numbers here. The US cannabis market size was valued at $10.8 billion in 2021. I mean, you cannot ignore you can’t ignore that, right? You,


Brian MacDonald  11:13

you can’t ignore it right. And what what’s remarkable is just the amount of growth that has taken place in the industry. And I know that Raphael, you’ll appreciate this. And it’s something that a lot of people in just general crowdfunding in general will speak about is the amount of jobs that it creates, the amount of jobs that it creates at the local community is really just it’s head scratching to some people, there are so many people that are now employed, involved in around just the general cannabis industry that rewind the clock a few years ago, they weren’t there. And as more and more states passed legislation, it’s just creating more and more opportunities. And people draw the kind of conclusion, okay, somebody’s going to open up a storefront, and there’s a retail store. And that’s kind of where they think it ends. But there’s so many other ancillary companies and industries that go around it, whether it be folks that are doing delivery, right, the folks that are actually growing the plant, if there’s a processing company, if there’s a co packaging company, right, if there’s people doing medical research around it. So it really does go far beyond just the storefront that a lot of people think is the end of the cannabis industry. That’s obviously one, one vital aspect, but there’s a whole lot more to it.


Rafael Gonçalves  12:29

Yeah, the ecosystem is huge, right? You have agriculture, you have the medical research, you have the storefront sales, the adult use, I mean, you have you have a huge ecosystem, it’s so much larger than we can then we can imagine. And, yes, you have jobs, you have taxes, you have research, you have legal dollars, right? That it’s a way to make the economy grow as well, right? Because it’s, it cannot be ignored. I cannot believe that, that he would take a $10 billion market and ignore it just for social reasons. I mean, it has to be discussed, of course, just like we do with alcohol. There are there are restrictions on alcohol usage and commerce throughout the world. And it’s fine. Right, but it’s fine it?


Brian MacDonald  13:20

Absolutely, absolutely. And there’s a lot of anecdotal information and statistical information that backs up the fact that throughout the pandemic, as people were in their homes and looking for other ways to kind of enjoy themselves or distress that alcohol sales specifically have been on the decline, whereas cannabis related sales, not only maintained but they actually picked up in some instances, and in many states, cannabis, dispensaries, retail dispensaries were deemed essential businesses throughout the entire lockdown. Whereas, you know, the local, it’s hard to believe, but even some restaurants or bars or things like that they were closed, and the cannabis retail dispensaries were open, which is kind of telling in and of itself.


Rafael Gonçalves  14:03

Wow, wow. Yeah. I read an article like, last week, or last month, I don’t remember exactly. But I read an article that was talking about the potential of, of, of cannabis, for sleeping, for the sleeping industry for the insomnia and people that haven’t insomnia issues. Like they can replace around 60% of the synthetic drugs. I mean, it’s it’s so much safer, you know, to just use a natural compound and work with it rather than develop a molecule out of the out of blue, you know, right? Wouldn’t it be safer if 60% of our medicines were natural? I mean, I think I think they would look


Brian MacDonald  14:46

well as as you said earlier, right? I’m not a scientist. These these things need to go through the FDA and go through the proper channels and we’re sure and that is one of the things that’s going to be interesting as this all evolves, right? Because there’s companies that want to make claims. And they want to be able to say that this helps sleep or give you energy or helps, you know, suppress hunger or helps your appetite. But they need to study it. And they have to have clinical trials. And all of that takes money. And you have to have research, and you have to be able to back it up and make your make your claims. And that ultimately goes back to what is one of the major choke points of the industry, access to capital, right access to capital, and access to the capital markets and access to traditional banking. So today is a step in the right direction. But there still needs to be a lot done in order for just the individual company to act and operate freely, just as if they were in any other industry. And if they’re able to do that, that will put this industry and the companies that operate within it in such a better place.


Rafael Gonçalves  15:55

Yes, yes. But we see that the cannabis sector is growing. You said that, that there’s a lot of an anecdotal facts, random facts around this this business. But what why do you believe it’s so controversial? Because of the bad aspect, the drug aspect? Why do we believe it’s too controversial?


Brian MacDonald  16:22

Yeah, I think a lot of it has to do with just personal experience and stereotypes around it. Right? Yes, just stereotypes. And if you grew up, and you were born in the 40s 50s, or 60s, alcohol was okay. Cannabis was a drug. It was a quote unquote, gateway drug. And it led you down some dark, evil path that you could never get out of, if you if you were a cannabis consumer. And that’s what that’s what everybody was trained to think, when in reality, if you look at not only the amount of people that are consuming cannabis, but the types of people that are consuming cannabis, it is not the stereotype of yesteryear, where, you know, the guy or gal is sitting on the couch, and you know, they have a bag of chips, never get up like that is that is not the case, there’s a lot of high profile, very famous, successful people that are advocates for the plant, enjoy it and view it as medicine. So I think it’s more just about the stereotype and people’s own personal views and personal personal kind of experiences. And as that becomes something of the past, and as we get to be in a place where this is more normalized, whether it’s for adult use, and just for your own personal, you know, whatever you want to view it as relaxation, distressing, or if there’s actual medical aspect to it. I think as this evolves, it’ll just change that stereotype. And you see that you see that, and there’s a lot of younger people call it the 18 to 25 demographic that are getting away from alcohol, that binge alcohol kind of society that was once there. It’s it’s still there for some people, but it’s definitely changing. And it’s definitely evolving. And I think cannabis is having a big part and a big impact as to why that’s happening.


Rafael Gonçalves  18:11

Yes, yes. Alcohol. Somehow in the past? I mean, I think 15-20 years, I don’t know. But the idea of drinking. It’s not fancy to drink anymore, you know, to get drunk and get high. It’s not fancy. Now, that’s that’s not fancy anymore. That’s not sophisticated. That’s red middle. Millennials. I don’t know. I don’t want I don’t like to talk about generations, because I confused the letters XYZ. I’m not quite sure. But But yeah, Alcohol Alcohol has been has been declining a bit. Right. Because maybe cannabis? I don’t know. But I mean, people are very conservative. We know that that in some places, we have conservative people. Canada, you will say Europe, I mean, a lot of places. Do you believe that? This, that fighting this stereotype is just a matter of time and research? Or do you believe that governments have to put putting more effort on advertising? And on public public messaging? How do you feel about it? Yeah, I


Brian MacDonald  19:19

think it does start with education. Right? Because if people don’t realize that there are health benefits associated with the plant, then they just view it and associated with however they already did. Right? So if there’s clinical studies as an example, or if there’s actual drug development and research that gives you statistical information that backs up a claim, whether that claim is around sleep deprivation, or hunger, you know, appetite disorders, whatever it might be, if there’s actual scientific proof to back it up. I think that will have a large, a large impact on changing people’s minds and change people’s perception as to what cannabis actually is. Um, but then yes, I think that if something were to happen at a federal level that would immediately change people’s minds, because there’s so many people that I say that I’m generally involved in the cannabis industry. And they’re like, oh, I don’t want to get arrested. Right? There’s nothing that I do that as anything. That’s, I’m not going to get arrested for being involved in the cannabis industry. Right. So I think it’s more just education, education. And that’s one of the things that we always talk about as education. Like I mentioned, the farm bill, as example, the Farm Bill made hemp completely legal. And that happened in 2018. So CBD exploded onto the scene after that bill was passed, people still think that that’s illegal, right. And that is just about education, and bringing awareness to it. And just like there was, you know, the whole war on drugs, there could be similar type of campaigns that talk about the benefits of this, that hopefully could kind of reverse that and put this on a completely different, different path.


Rafael Gonçalves  20:59

Yes, I believe that this is my personal view. I think that the medical use of CBD would be a trailblazer for other products. Because once something becomes medicine, FDA approved, and we’ll talk about the USA, once something becomes FDA approved. I mean, it’s safe, right? I think that medical use could be a trailblazer for the recreational. And for other uses of the product. I mean, this, this is something that we definitely have to go to go through. And as you said, clinical trials, they’re very expensive, right, very expensive. We saw what happened two years ago, with the COVID. And we saw many companies throughout the world, racing for the, to get the solution for that, you know, to get vaccines, and to sell them to spread them around the world. Clinical trials are truly expensive. And that’s why we’re here, right? Because we are this is also something we say to our KoreClients, our KorePartners, we’re not selling cannabis, we’re helping people get money. Right, right. We’re helping people we’re helping people to get capital to have access to capital. And especially when it talks about cannabis, we have regular reg CF, right? Because it’s a great opportunity for companies to turn brand advocates into shareholders and investors. Right. So how do you feel about that about reg CF for the cannabis business?


Brian MacDonald  22:34

Yeah, for for cannabis. Specifically, I think reg CF, could really be a game changer for so many companies, because of the regulations. And because of the way in which you can make a lot of this information publicly available to investors, it could not only change perception, but to your point, you could get your customers to be investors into your business. And if your customers become investors in your business, now, they’re not only loyal customers, but they’re brand advocates, and they’re going to do everything in their power to make sure and help you succeed. So I think reg CF being that, you know, yes, the old kind of version, if you will, of raising capital for private companies was a private placement, you had to be an accredited investor. Typically, the minimums were 100,000 250,000, etc. And not everybody had access to that not everybody had access to that deal flow, not everybody’s an accredited investor, not everybody could reach that 100,000 $250,000 minimum. And because of reg CF and the way in which it was it was written, you can have that minimum be as low as you want down to $100, right. So you can open it up to your community, you can open it up to your customers, you can open it up to to your fan base, you know, depending upon what your business is. And you can spread that message far and wide. And you can attract a lot of individual retail investors from within and outside of your community. So I think for cannabis, specifically reg CF, we’re very excited about where this goes and how we can play a part in it because the underlying linchpin of the industry is access to capital, access to capital and that’s both in capital markets, in banking and in private markets. And if we can, we can help open that up, I think will not only be in a good position for us to be successful, but ultimately help our companies be successful by just gaining attention and gaining awareness when in other in other situations before reg CF they wouldn’t have been able to do it reg CF and I put RegA plus in that as well.


Rafael Gonçalves  24:37

Yeah, of course, RegA plus, but But uh, we normally emphasize reg CF and talk about cannabis matters of the bread because of the brand advocate. I mean, usually this kind of product. The community is very, they’re very connected, right? So it should be easier for companies to succeed once they raise capital using the reg CF, because it’s easier for them to connect with. They’re just like Steve Jobs said, connect the dots. Right, right. Normally, these niche companies, they know exactly where their dots are, they know where to go. And they know how to navigate through this ecosystem. So reg CF can be a real game changer for for the whole sector for for cannabis. And that’s what that’s what we’re working for. Right? Educate. That’s what we’re doing right now. We’re, we’re trying to spread a little bit of education, right, to empower people through the private capital markets, as we can help them raise money. compliantly.


Brian MacDonald  25:41

Right. So absolutely. The one thing, one thing I’ll say, right mind is that going back to something you said earlier, goes back to the topic around CBD, and also just around kind of awareness and stigmas and perception. I think it’s a very interesting point. And you made me think of this, is that, right? Wrong, or indifferent? athletes and celebrities are people that are looked up to right, people viewed them as role models, in some situations, they emulate to be like them, and they take what they say, you know, very seriously, and they, they, you know, hold them to a very high standard. Well, it’s remarkable the amount of people from celebrity, whether they’re, you know, film stars, in the music industry, whatever it might be, as well as athletes that are coming into both the CBD and into the cannabis industry. But if you look at the athletes specifically, there’s very well known athletes that are Heisman winners that are Super Bowl winners that are, you know, in the Hall of Fame, that have endorsed products gotten and behind brands that are actual operators themselves have made investments into companies. And they are advocates because they know that the benefits of the plant helped them tremendously. Right. And to your point of as to like, the CBD being that that that one that gets in and kind of opens up the gate for other CBD. Again, you have to get the scientific kind of claims behind it. And you have to go through the FDA studies, but there are many people that feel that it helps them tremendously with joint pain, with muscle pain, with backaches, etc. So, as that becomes more widely and widely accepted and adopted, that will just make the rest of it that much easier.


Rafael Gonçalves  27:28

Yes, yes. Athletes? Yes. That’s, that’s something very, very good. It was a very good memory, because there are some athletes that are involved in the business. Yes. And, and, yes, role models, role models are very important, because they are a kind of stereotype as well, right? We normally use a stereotype as a negative word, but it’s not. It’s just a preconceived idea. It can be good, it can be bad, but I mean, right? It’s a stereotype is something you preconceived? Right, right. But and then and I’m sorry, good. No, no, please, please. Yeah. And then what I was going


Brian MacDonald  28:05

to say is that around your comment around crowdfunding and the marketing to your clients, obviously, the name is crowd funding, right? You need, you need a crowd, you need a crowd of people in order for the funding to be successful. And I think that’s why it could be so interesting and exciting as this evolves in the cannabis industry, specifically, because they do have such a loyal supporting group of people that are advocates for the brand. And one example would be the beverage market, the beverage market has grown tremendously, right. And it talks to the non traditional cannabis user coming into the cannabis space. Right? Are they going to smoke a joint like what they used to, you know, might, they may have been forced to do if they wanted to consume the plant. Now they can have a beverage right and to your earlier comment about drinking, and it being cool or fashionable right now if you’re at a cocktail party, and you have a cannabis, THC or CBD infused beverage. Now society from a societal perspective, you look like everybody else, you have a cocktail in your hand, and and you’re consuming it. And it just opens it up to a whole different demographic of people, specifically those that don’t like the actual smoke aspect. So just wanted to touch on a few topics that came to mind as you were speaking.


Rafael Gonçalves  29:25

No, no, no, it was great. And you talked about you talked about a Heisman Trophy winners. I just Googled here because I’m a Miami Dolphins fan. And I was right. My memory was right. Ricky Williams. He was a Miami Dolphins running back in the beginning of the 2000 2004. And he is in the cannabis business. I googled it as you were speaking. He played for the Miami Dolphins and he even got suspended once and he has a second stint of the dolphins. Ricky Williams, probably that are others but I just remember that because I am a Miami Dolphins fan. So, yeah, that just came. He wasn’t he was a very strong running back. I remember him.


Brian MacDonald  30:06

Yeah. Yes. Running back. Great, great person. And yes, he’s a very big advocate for the industry and for making a change. So yeah, he’s a great example. And there’s others like him. But yeah, that’s that’s a great example. Yeah, I


Rafael Gonçalves  30:21

really liked him. I really like Oh, my God, I’m not I’m not in my office. But if I if I was in my office, he would sit in the back here you’d see a small as well as more production of Miami Dolphins quarterback Tua I have I have a miniature of him. Aqua jersey. But yeah, but that’s very nice. That’s, that’s very nice. We talk about role models, we talk about stereotypes. And that’s, that’s basically it. We’re talking about education. But what are your expectations for the next couple of years in the business? I mean, this question, when I thought of this question yesterday, I had one scenario in mind, but now with the decriminalization, that with the pardon that Biden just signed, your answers probably going to be different.


Brian MacDonald  31:11

Yeah, and so it literally happened right before we got on here. So I don’t even truly know fully what it means in totality. But it’s a step in the right direction. And so it’s a step in the right direction as to things just get normalized. And if this becomes an industry that’s viewed, like any other industry, whether it’s alcohol or tobacco, they have to be highly regulated, right, you have to be of age. But as long as that’s the case, then you should be able to access capital markets, you should be able to access traditional banking and not get you’re charged fees that are significantly higher than any other industry in which you’re competing against. And there’s very specific aspects of cannabis industry that just puts the operators at an unfair advantage, specifically from a tax perspective. And so as this evolves, and as those things and those barriers get broken down, I think it’s going to be, you know, a very good industry and exciting industry to be in. And that’s why we’re so excited is that we can work with KoreConX, we can have companies come onto our platform, and we can help facilitate capital into private companies, that otherwise they wouldn’t be able to access this data. And we can do it in a very legal and compliant way. And we can accept that investor dollar, whether they want to do it in ACH form, they want to do it in a check, in a wire or even on their credit card, which you wouldn’t think are big deal, you wouldn’t think that’s a big deal. Because every other industry can do it. But for us to do it, it’s a big deal. So there’s just little things like that. But those little things add up to be very big things and there’s all those little things start to get chipped away, then hopefully, a few years from now we’re talking and this is just like any other industry. And, you know, there’s one aspect to the cannabis industry that as we speak to investors, it tends to come up a lot. And that is around real estate, right? So as real estate, real estate investors, they see this as an opportunity. Well, I draw a similar kind of comparison to data centers, right. There’s data centers, specific real estate funds out there, that they just focus on data centers. And then obviously, they occupied their building with a data center tenant, and they get paid their rent, well, the same thing should be for cannabis, right? We buy an industrial building, we get paid our rent, and as that evolves, then there will just be a specialized, like data center is a specialized REIT, you could have a specialized cannabis. So that is one example of many as to, you know, 2,3, 5 years from now. That’s ultimately where we get to a place like that.


Rafael Gonçalves  33:45

Yeah, and effectively, we are we are working on with cannabis inside the private capital markets. And if it’s legal, we know that a lot of countries they follow the USA, the FDA, and if if it’s if it becomes really legal in the USA, we know that in other countries, things tend to change as well. And the the regular banking system will be late, right? Because once you remove the risk from the cannabis business, I mean, the the bank, instead of the traditional banking system, they will have to come up with a solution, or how can we fund cannabis, but probably the cannabis business will have already found its alternative in the private capital markets. Right. So.


Brian MacDonald  34:28

Right, right. And that’s what’s going on so far to date is that if you ask the typical American, if they are able to invest in the cannabis industry, most of them will think the answer is no. Those that think that they can think that they can only do it through a public vehicle like a public security, or a public ETF that’s traded on a on an exchange, but that comes with its own challenges, because the US operators that are operating the United States can’t list on a US exchange. So there’s issues around that and that’s really what we’re excited about is just opening up the access to capital so that the individual American who doesn’t think that they can access this industry they can in these private emerging industries and companies. And so yeah, we’re super excited about about the future and obviously partnering with you guys on this. That’s


Rafael Gonçalves  35:17

very nice. That’s, that’s great. So I believe I believe we over half an hour, I believe we could go on for 5, 6, 7, 8 hours, maybe talking about that. But I believe we could, you could, we could finish we could wrap it up. If you have a final message of Brian, if you’d like to speak to our audience, please. The stage is yours. Go ahead as we can, as we can say our goodbyes. Yeah,


Brian MacDonald  35:44

absolutely. I will just wrap it up with a obviously a thank you to you and the partnership that we’ve that we’ve formed with core connects and then we’re we’re extremely excited to be the conduit to the industry. That’s the way that we view ourselves is that we obviously want to work with companies that are growing, that are accelerating that are going to be successful in the long run. But ultimately, what we want to do is we want to be that access point, as investors come into this industry view us as a resource view us as a partner, a source of knowledge and information, and then obviously, would love to partner with folks on future endeavors.


Rafael Gonçalves  36:20

Yes, that’s that’s very nice to hear. And we at KoreConX, we’re very happy to have ArcView on board as a great core partner. And we strongly believe that the cannabis business is a very good is a very good opportunity. It’s not a risk. It’s an opportunity, because things are happening and things will happen. We know that. So thank you all for listening to us for watching us. We are here on LinkedIn live, we are on podcasts. You can look it up a score talks on Spotify, Apple podcasts, Amazon music. We are here bi weekly. Who knows maybe we can be here more often. And sure, Brian, we’ll be back soon enough. And we will talk. We have plenty of more things to talk about the cannabis business and we have as event or KoreSummit coming up in October. Last week of October. It’s going to be amazing. Brian is going to be there. ArcView is going to be there as well. And we hope we can see everybody there. Thank you guys. See in the next time see you Brian and goodbye.


Brian MacDonald  37:19

Thank you Take care

Join the all-in-one platform empowering private capital markets.

Free forever, KoreConX makes it easy for participants in private capital markets to manage their investment portfolios, raise capital, and meet global compliance standards along every step of the way.

Book a demo